AllSight
Companies · PODD · Surgical & Medical Instruments & Apparatus

INSULET CORP (PODD)

INSULET CORP (PODD) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

INSULET CORP (PODD) stock — financials & valuation

Key numbers for INSULET CORP (PODD): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 60/100 — a percentile rank of INSULET CORP’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.

Market cap$9.1B
P / E24.2×
P / S3.0×
EV / EBITDA15.4×
Gross margin71.1%
Operating margin16.9%
Net margin12.3%
Return on equity26.4%
ROIC21.3%
Revenue growth29.4%
Debt / equity0.7×
Dividend yield0.0%

Is INSULET CORP overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from INSULET CORP’s own financial statements and shown as context, never as advice.

Sep 21, 2026Debt refinanced
Insulet refinances $475M debt at lower rates, expands credit cushion
Sep 16, 2026Deferred compensation plan
Insulet adds 2027 deferred-comp plan with optional employer contributions
Sep 10, 2026Board turnover
Insulet loses two long-serving directors as chairman exits for health reasons
Aug 5, 2026
Earnings beat, but a sharp U.S. growth reset cuts full-year outlook
Related companies in Surgical & Medical Instruments & Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact